Recent Executive Summaries (2023-2026)
CDDF Multistakeholder Workshop: Challenges in the Landscape of a Global Development Strategy Including Patient Access (30-31 March 2026)
CDDF Annual Conference 2026: Cancer Clinical Research in a Changing Global Environment (9-11 February 2026)
CDDF Multistakeholder Workshop: Enabling Smarter Clinical Trials to Optimise Patient care (17-18 November 2025)
CDDF Multistakeholder Workshop: New Modalities in Cancer Drug Development (31 March – 1 April 2025)
CDDF Annual Conference: In Challenges, Andvances, and Open Questions in Global Cancer Drug Development and Clinical Trial (3 – 5 February 2025)
CDDF&EORTC Multi-Stakeholder joint Workshop: Innovation and Access in Rare Cancers (23 – 24 September 2024)
CDDF Multistakeholder Workshop in Central and Eastern Europe: New Approaches for the Next Level of Development (15-16 April 2024)
CDDF Multi-Stakeholder Workshop: The critical role of Biomarkers (13-14 November 2023)
CDDF Multi-Stakeholder Workshop: Innovative oncology trial designs (18-19 September 2023)
CDDF Multi-Stakeholder Workshop: Dose optimisation in early oncology drug development (3-4 April 2023)
CDDF Annual Conference 2023: Challenges in clinical trial performance (6-8 Feb 2023)
Past Meeting Reports
- CDDF Multi-stakeholder workshop on Histology Independent Drug Development: Is this future for cancer drugs? (Nov, 2022)- read the report
- CDDF Multi-stakeholder workshop on the Endpoints in Cancer Drug Development, April 2021 – read the report
- CDDF 12th Spring Conference 2021 – read the report
- CDDF 11th Spring Conference 2020 – read the report
- CDDF Multi-stakeholder workshop on the Use of Real-World Data to Optimize Oncology Drug Development and Access, November 2019 – read the report
- CDDF Multi-stakeholder workshop on Involving Patients In Oncology Drug Development, June 2019- read the report
- CDDF Multi-stakeholder workshop on Impact of the Microbiome on Cancer Growth and Therapy – read the report
- CDDF Multi-stakeholder workshop on Minimal Residual Disease in AML – CLL, Nov 2018 – read the report
- CDDF Multi-stakeholder workshop on Biomarkers and Patients’ Access to Personalized Oncology Drugs in Europe, 2018 – read the report
- CDDF 10th Alpine Conference on Current and Future Challenges of Innovative Oncology Drugs Development, 2018 – read the report
- CDDF Multi-stakeholder workshop on Minimal Residual Disease, 2017 – read the report
- CDDF-ENCA-ITCC-SIOPE 3rd Paediatric Oncology Conference, 2015 – read the report
- 8th CDDF Alpine Conference, 2015 – read the report
- ITOC-2, 2015 – read the report